CN Patent

CN105636594A — 使用雄激素靶向疗法用于治疗肿瘤性疾病的生物标记物

Assigned to University of Washington · Expires 2016-06-01 · 10y expired

What this patent protects

本发明所述的用于治疗需治疗对象的前列腺癌的方法和组合物。所述前列腺癌可以是对去势治疗有抗性的和对雄激素受体拮抗剂有抗性的前列腺癌。该方法可以包括向对象给予式II的CYP17裂解酶抑制剂。

USPTO Abstract

本发明所述的用于治疗需治疗对象的前列腺癌的方法和组合物。所述前列腺癌可以是对去势治疗有抗性的和对雄激素受体拮抗剂有抗性的前列腺癌。该方法可以包括向对象给予式II的CYP17裂解酶抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN105636594A
Jurisdiction
CN
Classification
—
Expires
2016-06-01
Drug substance claim
No
Drug product claim
No
Assignee
University of Washington
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.